Literature DB >> 20084150

Persistent fetal circulation.

C D'cunha1, K Sankaran.   

Abstract

Persistent fetal circulation (PFC), also known as persistent pulmonary hypertension of the newborn, is defined as postnatal persistence of right-to-left ductal or atrial shunting, or both in the presence of elevated right ventricular pressure. It is a relatively rare condition that is usually seen in newborns with respiratory distress syndrome, overwhelming sepsis, meconium and other aspiration syndromes, intrauterine hypoxia and ischemia, and/or neonatal hypoxia and ischemia. This condition causes severe hypoxemia, and, as a result, has significant morbidity and mortality. Improved antenatal and neonatal care; the use of surfactant; continuous monitoring of oxygenation, blood pressure and other vital functions; and early recognition and intervention have made this condition even more rare. In modern neonatal intensive care units, anticipation and early treatment of PFC and its complications in sick newborns are commonplace. Thus, severe forms of PFC are only seen on isolated occasions. Consequently, it is even more imperative to revisit PFC compared with the time when there were occasional cases of PFC seen in neonatal intensive care units, and to discuss evolving treatment and management issues that pertain to this syndrome.

Entities:  

Keywords:  Newborns; Persistent fetal circulation; Persistent pulmonary hypertension of the newborn; Respiratory distress syndrome

Year:  2001        PMID: 20084150      PMCID: PMC2805987          DOI: 10.1093/pch/6.10.744

Source DB:  PubMed          Journal:  Paediatr Child Health        ISSN: 1205-7088            Impact factor:   2.253


  64 in total

1.  Randomized, multicenter trial of inhaled nitric oxide and high-frequency oscillatory ventilation in severe, persistent pulmonary hypertension of the newborn.

Authors:  J P Kinsella; W E Truog; W F Walsh; R N Goldberg; E Bancalari; D E Mayock; G J Redding; R A deLemos; S Sardesai; D C McCurnin; S G Moreland; G R Cutter; S H Abman
Journal:  J Pediatr       Date:  1997-07       Impact factor: 4.406

Review 2.  Continuous renal replacement therapy in critically ill patients.

Authors:  G Zobel; S Rödl; B Urlesberger; M Kuttnig-Haim; E Ring
Journal:  Kidney Int Suppl       Date:  1998-05       Impact factor: 10.545

Review 3.  Persistent pulmonary hypertension of the newborn.

Authors:  L J Tiefenbrunn; T A Riemenschneider
Journal:  Am Heart J       Date:  1986-03       Impact factor: 4.749

Review 4.  Recent developments in the pathophysiology and treatment of persistent pulmonary hypertension of the newborn.

Authors:  J P Kinsella; S H Abman
Journal:  J Pediatr       Date:  1995-06       Impact factor: 4.406

Review 5.  Nitric oxide and reactive oxygen species in vascular injury.

Authors:  H Rubbo; M Tarpey; B A Freeman
Journal:  Biochem Soc Symp       Date:  1995

6.  Inhaled nitric oxide for the adult respiratory distress syndrome.

Authors:  R Rossaint; K J Falke; F López; K Slama; U Pison; W M Zapol
Journal:  N Engl J Med       Date:  1993-02-11       Impact factor: 91.245

7.  Cerebral infarction in persistent pulmonary hypertension of the newborn.

Authors:  K W Klesh; T F Murphy; M S Scher; D E Buchanan; E P Maxwell; R D Guthrie
Journal:  Am J Dis Child       Date:  1987-08

8.  Long-term follow-up of newborns with persistent pulmonary hypertension.

Authors:  J C Bernbaum; P Russell; P H Sheridan; M H Gewitz; W W Fox; G J Peckham
Journal:  Crit Care Med       Date:  1984-07       Impact factor: 7.598

9.  Effects of prostacyclin on the fetal pulmonary circulation.

Authors:  S Cassin; I Winikor; M Tod; J Philips; J Frisinger; J Jordan; C Gibbs
Journal:  Pediatr Pharmacol (New York)       Date:  1981

10.  Nitric oxide regulation of superoxide-dependent lung injury: oxidant-protective actions of endogenously produced and exogenously administered nitric oxide.

Authors:  H H Gutierrez; B Nieves; P Chumley; A Rivera; B A Freeman
Journal:  Free Radic Biol Med       Date:  1996       Impact factor: 7.376

View more
  1 in total

1.  Persistent Pulmonary Hypertension of the Newborn: The Efficacy Comparison of Vasodilators Sildenafil Plus Bosentan Versus Sildenafil Plus Beraprost at a Tertiary Childcare Health Facility.

Authors:  Mudasser Adnan; Muhammad Sohail Arshad; Hafiz Muhammad Anwar-Ul-Haq; Munir Ahmad; Hira Afsheen; Hashim Raza
Journal:  Cureus       Date:  2021-11-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.